期刊
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
卷 57, 期 -, 页码 132-137出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2017.01.036
关键词
Parasitic load; Small subunit ribosomal RNA gene; Leishmania (Viannia) braziliensis; Therapeutic failure
资金
- FIOCRUZ
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
- PROEP/CNPq [400124/211-4]
- PAPESVI/CNPq [407449/2012-4]
Background: Leishmania (Viannia) braziliensis is the main etiological agent of tegumentary leishmaniasis in the Americas. Parasite molecular diversity and host immune status contribute to extensive variations in its clinical presentation within endemic areas of Brazil. Pentavalent antimonials have been used for more than 60 years as the first-line drug for all cases, despite the potential for severe side effects and refractoriness. In Rio de Janeiro, Brazil, most L. (V.) braziliensis infections are benign with a scarcity of parasites, although metastasis and refractory infections can arise. In this scenario, the use of novel molecular tools can be useful for diagnosis and to assess tissue parasitism, and is of benefit to clinical and therapeutic management. Methods: In this study, parasite load was assessed by real-time PCR based on the leishmanial small subunit ribosomal RNA gene. Results and conclusion: The data revealed a tendency to higher tissue parasitism in the skin compared to mucous lesion sites and a reduction with disease progression. Parasite load was lower in poor compared to good responders to antimonials, and was also reduced in recurrent lesions compared to primary ones. However, parasite load became higher with sequential relapses, pointing to an immune system inability to control the infection. Therefore the parasite burden does not seem to be a good predictor of disease progression. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据